Trial intelligence / Profile preview

Esketamine infusion dose comparison under sevoflurane anesthesia in urologic laparoscopic surgery

ChiCTR2300075902Phase 4Not yet recruiting

Sponsor
The First Affiliated Hospital of Zhengzhou University
Start
Sep 2023
Modality
Small Molecules
Countries
1
01

Overview

Phase 4 trial of esketamine (3 arms), sponsored by The First Affiliated Hospital of Zhengzhou University. Primary endpoint: bispectral index. Planned start Sep 2023; status: not yet recruiting.

02

Drugs

esketamine

Beyond the preview

Go deeper on ChiCTR2300075902.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on ChiCTR2300075902.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call